TDP-1 constitutes a promising target in cancer treatment; therefore, the development of inhibitors may be useful to improve the efficacy of chemotherapy (Dean et al., 2014; Mozhaitsev et al., 2019; Khomenko et al., 2020; Mamontova et al., 2020). This evidence concerns the gene TDP1 and cancer.